This Ollie’s Bargain Outlet Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
1
0
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Piper Sandler analyst David Amsellem downgraded Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) from Overweight to Neutral and lowered the price target from $66 to $36. Amphastar Pharma shares closed at $33.39 on Monday. See how other analysts view this stock.
- Baird analyst Peter Arment downgraded Triumph Group, Inc. (NYSE:
Full story available on Benzinga.com
Visited 1 times, 1 visit(s) today